title: Sugammadex and residual neuromuscular block: what is acceptable normal practice?
authors: Iowa, IA, USA michael-todd@uiowa.edu.
authors: M M
authors: MM
authors: Todd
mesh_terms: D000732:Androstanols / Q000037:antagonists & inhibitors*; D055191:Delayed Emergence from Anesthesia / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D009469:Neuromuscular Junction / Q000187:drug effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D047408:gamma-Cyclodextrins / Q000494:pharmacology*
chemical_list: D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins